Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2020-03-26 | 2021-01-28 | 109562 |
| TEVA-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2017-04-03 | 2017-05-10 | 5177 |
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2021-03-25 | 2021-04-01 | 136329 |
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2025-11-20 | 2025-12-18 | 272298 |
| TEVA-CLINDAMYCIN | 150MG | CAPSULE | Actual shortage | 2025-10-10 | 2025-10-10 | 269217 |
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2017-04-03 | 2017-10-24 | 5180 |
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2024-02-08 | 2024-04-05 | 218960 |
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2021-02-11 | 2021-03-25 | 133782 |
| TEVA-CLOBAZAM | 10MG | TABLET | Resolved | 2021-02-05 | 2021-02-11 | 133467 |
| TEVA-CLOBAZAM | 10MG | TABLET | Resolved | 2024-05-30 | 2025-02-21 | 229230 |
| TEVA-CLOBAZAM | 10MG | TABLET | Resolved | 2023-08-18 | 2023-10-04 | 202490 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2025-01-30 | 2025-02-06 | 249195 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-03-26 | 2020-04-09 | 109610 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-01-19 | 2023-01-26 | 181611 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2020-08-27 | 2020-09-25 | 123084 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-08-20 | 2020-12-17 | 122693 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2024-06-27 | 2024-08-08 | 231421 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2020-01-30 | 2020-04-09 | 104917 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2024-08-30 | 2024-10-17 | 236359 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2025-01-09 | 2025-02-20 | 247319 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CEFTRIAXONE SODIUM FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258691 |
| CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2025-05-27 | 2025-05-27 | 258359 |
| CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2021-02-12 | 2021-02-12 | 133886 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| COUGH SYRUP WITH CODEINE | 30MG 3.3MG 100MG | SYRUP SYRUP | Reversed | 2025-05-28 | 2025-06-03 | 258600 |
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 |